<?xml version="1.0" encoding="UTF-8"?>
<p>Demographic characteristics included age, education, marital status, and length of incarceration. HIV treatment factors included diagnosis date and location (i.e., prison or community), current or previous use of ART, and CD4
 <sup>+</sup> T-lymphocyte count. Frequency of drug use/injection in the three months before incarceration was assessed using the Texas Christian University Drug Screen, which was previously adapted [
 <xref rid="pone.0234697.ref037" ref-type="bibr">37</xref>, 
 <xref rid="pone.0234697.ref061" ref-type="bibr">61</xref>]. To assess pre-incarceration sex behaviors, participants were asked whether or not they were sexually active (defined as penile-vaginal or penile-anal intercourse) with men, women, and/or transgender women (known locally as 
 <italic>waria</italic>) in the 6 months before the current prison term. To reduce social desirability bias, participants were first asked whether they preferred sex with men, women, 
 <italic>waria</italic> or some combination of the three. To reduce recall bias, questions about pre-incarceration drug and sex risk behaviors used an “anchoring event”. Because this study sought to ascertain the acceptability of provider referral for notifying partners in the community, participants were not asked about sexual activity in prison.
</p>
